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Abstract Contrast flow and enhancement patterns seen on
thoracic CT angiography (CTA) can often be challenging
and may often reveal more than is immediately apparent.
A non-diagnostic CTA following the initial contrast injec-
tion can be secondary to many causes; these include both
extrinsic factors, such as injection technique/equipment
failure (iv cannula, power injector), and intrinsic,
patient-related factors. Contrast pressure and flow graphs
often contain useful information regarding the etiology of
a non-diagnostic scan. Understanding these graphs will
help the radiologist plan a repeat contrast injection to
overcome the deficiencies of the first injection and thus
obtain a diagnostic scan. The current review article out-
lines normal and abnormal intravenous contrast dynamics,
discusses how to recognize etiologies of non-diagnostic
scans, and ultimately addresses techniques to overcome
obstacles towards obtaining normal contrast opacification
of the target vessel. In addition, there are some life-
threatening findings, which unless sought for, may remain
hidden in plain sight.
Key Points
•Using contrast enhancement and flow patterns to identify the
cause of a non-diagnostic CTA.
• Recognize life threatening causes of altered contrast dynam-
ics such as cardiac asystole.
• Non-target vessel opacification may hold key to underlying
pathophysiology.
Keywords CTangiography . Non-diagnostic CTA . Contrast
dynamics . Cardiac asystole . ECMO
Introduction
There is progressively increasing use of CT scans in the emer-
gency department (ED) in recent years [1]. Chest pain is the
second leading presenting symptom in ED patients (5.2 %)
[2], thus thoracic CT angiography (CTA) has become one of
the most commonly ordered CTA in ED. Indications for tho-
racic CTA include pulmonary embolus, acute aortic syn-
drome, or coronary artery disease. Contrast flow and enhance-
ment patterns seen on CTA can often be challenging and may
often reveal more than is immediately apparent. In addition to
target vessel opacification, evaluation of non-target vessels
may also contain important clues to the underlying disease
that brought the patient to the ED. In addition, there are some
life-threatening findings, which unless sought for, may remain
hidden in plain sight. Also, contrast pressure and flow graphs
obtained with the CTA often contain useful information re-
garding the etiology of a non-diagnostic scan (Table 1).
Understanding these graphs will help the radiologist plan a
repeat contrast injection to overcome the deficiencies of the
first injection and thus obtain a diagnostic scan.
In this article, we will review several abnormal contrast en-
hancement and flow patterns that are encountered in thoracic
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CTA, including severe abnormalities such as right heart strain,
cardiac asystole, and cardiac tamponade. In addition, we will
also revisit key components of intravenous contrast delivery
including, but not limited to power injector, intravenous cannula
size, flow rate, and access vein size.
Obtaining a diagnostic thoracic CT angiography
(CTA)
An optimal, diagnostic thoracic CTA study is never obtained
by accident. It requires active technologist and often radiolo-
gist input throughout the planning, execution, and post-
processing stages.
The physical components of a CTA include the CTscanner,
intravenous cannula, access vein size, and power injector; the
functional component is the patient’s cardiac status. Optimal
functioning and seamless integration of every individual piece
of this continuum is crucial to ensure optimal contrast
opacification of the target vessel, and thus, a diagnostic study,
since Ba chain is only as strong as its weakest link^. Through
the following text, we will address the important pieces of this
fine-tuned sequence and how malfunction of any individual
component can limit attempts to obtain a diagnostic study.
With this end goal in mind, understanding the anatomy and
physiology of the cardiovascular system as it pertains to con-
trast flow dynamics can serve as a useful starting point.
Blood/contrast flow dynamics and cardiac function
Central veins of the thorax convey blood/contrast bolus to the
right atrium. Blood then enters the right ventricle across the
tricuspid valve. Further, the right ventricle propels the blood/
contrast medium into the pulmonary artery from where it en-
ters the pulmonary vein and then the left atrium. Mitral val-
vular opening and left atrial contraction ensure onward flow of
blood/contrast bolus into the left ventricle; systolic contraction
of the left ventricle further propels blood/contrast bolus into
the aorta and its branches.
Normal flow of intravenous contrast through a commonly
used upper extremity venous access site follows a pattern;
contrast flows first into the brachiocephalic vein, then into
the superior vena cava, right atrium, right ventricle, pulmo-
nary artery, pulmonary vein, left atrium, left ventricle, ulti-
mately to opacify the ascending and then the descending aorta.
Any disruption of the above-described normal sequence of
events should be treated with suspicion. For example, contrast
enhancement of a distal chamber before adequate
opacification of a proximal vessel/chamber is never normal.
Similarly, persistent enhancement of a proximal segment
Table 1 Different causes of abnormal contrast flow, key imaging findings and solutions to obtain a diagnostic CTA
Etiology of altered contrast flow Key imaging features Solution
Access cannula and vein mismatch 1. Suboptimal target vessel opacification
2. Injection flow rate may be lower
than planned
1. New cannula or access vein
2. When access veins are small: Dual energy scan
with 50–60 keV monoenergetic reconstruction
Incorrectly placed region of interest 1. Assess location of region of interest from
the bolus tracker/ bolus timing images
Correct placement of ROI, reinjection, and reimage
Extravasation 1. No target vessel opacification
2. Contrast presence in soft tissues of
access vein extremity
1. New cannula and access vein at a different site
Thoracic venous outlet obstruction 1. Contrast pooling in the collaterals
around axilla & chest wall
1. Asymptomatic: reinjection with arm down position
2. Symptomatic: new access site in contralateral extremity
Transient interruption of contrast bolus 1. Transient decreased contrast attenuation.
2. Presence of normal contrast in upstream
vessels
1. Shallow breath hold
2. End expiratory imaging





Differential enhancement in aorta 1. Multiplanar reformats to evaluate coarctation, shunts.
Mixing artifact in aorta Contrast blood level, dependent pooling
of contrast
1. Assessment of cardiac function
Repeat delayed (30 sec) limited Z axis scan
Mixing artifact in left atrium Contrast blood level in left atrium,
pulmonary veins
Assessment of cardiac function
Poor opacification of left ventricle No opacification of left ventricle on a
pulmonary artery CTA
Assessment of cardiac function
Early enhancement on left
compared to right heart
Intracardiac shunt Assessment of cardiac function
Asystole Dependent pooling of contrast in central veins, liver Initiate cardiopulmonary resuscitation and page
the code team
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when most of the contrast has washed out from the distal
segments is not normal. When present, these findings should
raise the suspicion of altered flow dynamics including under-
lying intra- or extra-cardiac shunt.
Traditionally, ECG gated CT/MR have been used to
define cardiac chamber enlargement. However, recent
literature has suggested threshold measurements to identify
left atrial enlargement (transverse diameter: 73 mm,
anteroposterior diameter: 43 mm) [3] and left ventricle enlarge-
ment (56mm)[4]onanon-ECGgatedCTA.For the right atrium,
usually the normal diameters suggested by echocardiographyon
four-chamber view have been used: right atrium (long-axis
dimensions 3.4–5.3 cm and 2.6–4.4 cm for short axis) and for
right ventricle (basal dimensions 3.9–4.5 cm and longitudinal
dimension 8–9.1 cm) [5].
Normal circulation
The pulmonary artery to ascending aorta transit time (PTT)
is a key circulatory parameter that can affect target, as well
as non-target vessel opacification on a thoracic CTA. PTT
can be calculated by evaluating the time attenuation graph
obtained from the test bolus (Fig. 1). In normal subjects,
this is about 6.8 ± 1.7 s [6]. In patients with pulmonary
hypertension or congestive heart failure (CHF), pulmonary
circulation can be slow and PTT will be prolonged, which
may lead to delayed contrast arrival in the non target ves-
sel, e.g. in cases of a pulmonary artery CTA, this implies
delayed aortic opacification.
CT scan
There may be more than one type of CT scanner within the
same hospital system. Understanding the type of CT scan-
ner used is important as scan parameters such as transit
time, acquisition time, applied kVp and mAs may differ
between scanners. Importantly, the scan delay and total
acquisition time may vary depending on the scanner
(Table 2). These parameters can be altered to reduce
contrast volume in patients with diminished renal function
or when a repeat injection becomes necessary in event of
an initial, non-diagnostic scan. When using a scanner with
shorter acquisition time, non-target vessel enhancement
may be less than expected and these vessels should be
interpreted with caution.
Imaging pearl: Know the transit delay and scan acquisition
time of the CT scanner. Modify the injection protocol and
post-threshold delay based on these factors. Post-threshold
delay needs to be increased when using a faster scanner to
better opacify the non target vessels. For example, for a
Fig. 1 Test bolus technique for identification of contrast arrival in target
vessel. Prolonged pulmonary circulation time in a patient with aortic
stenosis. CT image during test bolus injection (a) with regions of
interest over the ascending aorta (1), descending aorta (2) and
pulmonary artery (3). Attenuation-time graph corresponding to the re-
gions of interest (b) shows prolonged pulmonary circulation time of
16 s in this patient due to aortic stenosis (normal pulmonary transit time
is approximately 7–9 s)
Table 2 Key differences in the
different parameters of the
commonly used CT scanners
Collimation Pitch Gantry rotation time (s) Scan delay time (s) Total scan time (s)
64 slice 64 × 0.625 0.6–1 0.75 4.2 7–9.4
128 slice 64 × 0.625 0.6–1 0.40 4.2 4–7
256 slice 128 × 0.625 × 2 0.6–1 0.33–0.4 4.2 3–6
Dual source
FLASH
2 × 128 × 0.625 1–3.2 0.28 3–6.0 1.1–2
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pulmonary embolus study, we use a post-threshold delay of at
least 5 s on a 64 slice scanner, but a longer delay of 8 s is used
on a 256 or a dual source scanner.
CTA techniques
Contrast arrival in the target vessel can be determined by using
test bolus or bolus tracker technique [7, 8]. Evaluating the time
attenuation curves generated by either of these techniques is
important to understand normal and abnormal contrast arrival
and pulmonary transit time.
In test bolus technique, a small amount of contrast is
injected followed by saline chaser at the predetermined flow
rate to identify contrast arrival in target vessels. It assumes that
the bolus geometry of this initial injection and the final injec-
tion for the diagnostic scan would remain the same (Fig. 1). In
bolus tracking technique, only one injection is performed at
the planned flow rate. The scan is initiated as soon as the
contrast enhancement threshold (predetermined threshold
HU) is reached within the region of interest. The time taken
from when this threshold is achieved to the actual beginning
of the diagnostic scan depends on multiple factors including
the scanner type and distance of this bolus tracker location
with reference to the first slice of the acquisition. This is called
the transit delay (Table 2) and varies from patient to patient
and scanner to scanner.
Both these techniques, however, depend on correct identi-
fication of target vessel to place the region of interest where
change in attenuation is being measured. If this location is
incorrect, such as a false lumen of an aortic dissection, the
attenuation may not reach the threshold and the scan may
not be initiated (Fig. 2).
Imaging pearl: In patients with known heart failure, test
bolus can be more useful in identifying time to peak enhance-
ment, which can be delayed compared to contrast arrival time.
Intravenous cannula
Size of the cannula used for delivery of contrast medium is
important to achieve the desired flow rate for the duration of
the injection [9]. Peak flow rate needed varies on the indica-
tion for the CTA: preferred flow rate for pulmonary artery
CTA is 3–5 cc/s [10], for aortic evaluation is > 3 cc/s [11],
and for coronary artery assessment is > 5 cc/s [12] (Table 3).
Access vein
The peak flow rate that can be achieved also depends on the
size of the access vein [9] (Table 4). It is important to identify
Fig. 2 Bolus tracking technique for identification of contrast arrival.
Patient with descending aortic dissection with suboptimal increase in
contrast opacification within the region of interest (ROI) and failure to
trigger the scan (a). The initial CTA ROI was placed in the false lumen
(b). The contrast opacification of the false lumen does not reach the
threshold required to trigger the scan as seen on on bolus tracker HU-
time graph. Repeat injectionwith placement of ROI in true lumen resulted
in adequate evaluation of dissection
Table 3 Peak flow rate used at our institution based on manufacture
recommendations and ACR guidelines






18 g 5 cc/sec 300 YES YES
20 g 4 cc/sec 300 YES YES
22 g 1 cc/sec 300 YES YES
24 g Not recommended N/A YES NO




Antecubital/forearm All power injection
Central venous catheter* <2.5 mL/s
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this before the injection is initiated as a mismatch can lead to
either power injector induced reduction in flow rate of the
injection due to peak pressure being reached (Fig. 3a), leak
at the level of the hub (Fig. 3b) with abrupt cessation of flow,
or contrast medium extravasation.
Power injector
Powerinjector isusedto injectcontrastmediumandsalinechaser
at a constant flowrate for the entiredurationof the injection.Two
graphsaregeneratedbythepower injector,whichplot thechange
inpressureover timeandflowrateof the injectionover time(3A,
B). Evaluation of these graphs is important in identifying the
planned flow rate and any changes to that. In case of an access
vein size and i.v. cannulamismatch the pressuremay exceed the
threshold, which may limit the flow rate. This has important
implications for a diagnostic scan, especially pulmonary CTA
as the injection may not occur at the peak rate planned thus
leading to suboptimal opacification. Interpretation of these
graphs can help identify the cause of a nondiagnostic scan in
the first place and what parameters need to be changed before
we plan a reinjection.
Imagingpearl:Checktheaccessveinandaccesscannulabefore
initiating contrast injection. In patients with small caliber access
veins, a dual energy acquisition can be obtained. Lower (40–
60 KeV) monoenergetic reconstruction can be obtained to boost
contrastopacification.Whenadualenergyscannerisnotavailable,
Fig. 3 Graphs and tables from the power injector: pressure-time and flow
rate-time graphs. In a patient with contrast flow rate above the recom-
mended maximum (a). The planned flow rate of 5.4 mL/s using an 18 g
IV exceeded the recommended maximum of 5.0 cc/s. This resulted in
peak pressure reaching 300 psi with resultant disarming and decreased
flow rate of 2.8 mL/s with suboptimal pulmonary artery enhancement.
Power injector pressure-time and flow rate-time graphs in a different
patient with IV infiltration during the injection (b) shows rapid drop in
pressure and cessation of flow at the time of contrast extravasation
Fig. 4 a Extravasation of intravenously injected contrast material.
Coronal reformatted CECT images depicts extravasated contrast in the
upper extremity soft tissues. b: CT scout image after extravasation of
intravenously administered contrast in the left upper extremity allows
assessment of the extent of extravasation and permits evaluation of
possible compartment syndrome
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weusea largervolume(1.5mL/kg)ofcontrastmediumcontaining
350mgI/mL iodine and use 80 or 100 kVp for image acquisition.
Technical causes of poor contrast opacification
of target vessel of interest
Incorrectly placed ROI
Inappropriate placement of ROI for bolus tracking scan is a
common cause of non-diagnostic CT scan. Human error is a
common source of inappropriate placement. Selection of the
wrong target vessel, especially in the setting of complex vas-
cular anatomy, and/or selection of an ROI which is too big or
too small are common operator dependent errors. Patient
movement between localizer slice selection/ROI placement
and the start of contrast administration/imaging can also affect
ROI placement (i.e. large respiratory effort, cardiac motion,
and/or the patient physically shifting on the table), leading to
premature, delayed or even no bolus triggering. In addition,
intraluminal abnormalities, including dissection and embolus,
may not be readily apparent on the precontrast localizer im-
ages and placement of the ROI overlying one of these struc-
tures may result in delayed or absent bolus triggering. For
example, if the ROI is placed in the false lumen of a type B
aortic dissection (Fig. 2), the contrast enhancement may or
may not rise as quickly as expected (2). To avoid this, the
indication of the scan should be well known to the operating
technologist. A test bolus is preferable to bolus tracking in
patients with post-surgical repair of complex congenital heart
diseases.
Imaging pearl: In patients with known aortic dissection,
test bolus can be more useful in identifying time to peak
enhancement in true and false lumens. Optimal time for ac-
quisition would be when both lumens are opacified. If false
lumen dose not opacify at all on the bolus timing scan, a
limited Z axis 60 s delayed image can be obtained to confirm
slow flow/ thrombus or for follow-up, contrast-enhanced
MRA may be obtained.
Extravasation
Extravasation of contrast material, in which contrast medium
is injected outside the intended vessel, is an infrequent, but
well known complication of CTA (Fig. 4a). Contrast
Fig. 5 Thoracic venous outlet obstruction of the left subclavian vein with
the left arm raised for CTPA, which subsequently resolves upon
positioning the arm down at the side. Axial CECT following the rapid
bolus of intravenous contrast in the left upper extremity with the left arm
raise (a) shows narrowing of the left subclavian vein at the thoracic inlet
and contrast filling multiple small collateral veins in the left shoulder
region. The narrowing of the left subclavian vein prevented adequate
opacification of the pulmonary artery. Repeat injection with the left arm
down by the patient’s side (b) shows excellent opacification of the left
subclavian vein and no filling of venous collaterals, permitting a
diagnostic scan for evaluation of pulmonary embolus
Fig. 6 Chronic left subclavian vein thrombus with venous collateral
formation. Axial CECT after injection of intravenous contrast in the left
upper extremity shows a large filling defect in the left subclavian vein
(arrows) and multiple venous collaterals in the left shoulder region.
Unless the vessel is patent, additional studies should be performed with
a contralateral upper extremity injection to permit adequate contrast
opacification
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extravasation rates during CT imaging range between 0.1 and
0.9%, with an average rate of 0.4% [13, 14]. Patients at risk for
contrast extravasation include infantsandsmall children,elderly,
uncooperative, andunconsciouspatients, as theymaynotbeable
to communicate or complain of pain reliably during injection.
Patients receiving chemotherapy also have an increased risk due
to fragile, damaged, and often small caliber vessels. In addition,
useofdistalaccesssites (i.e.handor foot),useofpower injection,
use of a vessel with multiple puncture attempts, and use of a
peripheral IV that has been in place >24 h can also increase the
risk of extravasation [13–15]. Contrast extravasation should be
considered if the power injector demonstrates unexpected rapid
drop in pressure or exceeds the pressure limit with sudden de-
crease in flow rate before the full volume of contrast is adminis-
tered to the patient. Radiograph or CT topogram imaging of the
affected limb following an extravasation event may be useful to
determine the magnitude of infiltration and verify if compart-
mentation is present (Fig.4b) [15]. If somecontrast hasgone into
the patient, the study may still be salvageable. This should be
reviewedby the radiologist. If contrast is suboptimal, sometimes
it canbeamplifiedbyusingvirtualmonoenergetic images froma
dual energy scanner.Byusing lowenergyvirtualmonoenergetic
images, the energy levels of which are closer to the K edge of
iodine, the contrast signal is amplified which can potentially
salvage some suboptimal studies. However, if the study is not
salvageable or if no contrast went into the area of interest, the
study will have to be repeated. This can be done immediately if
there is another venous accessor later after obtainingappropriate
venous access.
ACRManual on Contrast Media discusses the treatment of
contrast extravasation [9]. Raising the affected limb above the
level of the heart may reduce swelling and facilitate absorption
of extravasated fluid. Some favor cold compresses to decrease
pain at the extravasation site and others prefer warm com-
presses to improve blood flow to the extravasation site and
increase absorption of the contrast from the tissues into the
vasculature and lymphatics. In addition, attempts to remove
the extravasated contrast via aspiration have not been shown
to be consistently beneficial. Regardless of the post-
extravasation treatment method, patients should be evaluated
by the radiologist. If pain is the main symptom, we use cold
compresses, and if the extravasation has occurred in a location
where there is a higher likelihood of compartment syndrome,
we use hot compresses. We observe the patient in the radiol-
ogy department for at least 1 h to ensure that there are no new
symptoms, such as pain or numbness to suggest development
of compartment syndrome. Before discharge, a radiologist
discusses the findings that would suggest a developing com-
partment syndrome with the patient. The patient is instructed
to seek medical attention if new neurologic or circulatory
symptoms or skin ulceration develop [9].
Thoracic venous outlet obstruction
Thoracic outlet syndrome (TOS) refers to the effects of dy-
namic compression of the nerve, artery, and/or vein as these
structures cross the thoracic outlet due to changes in arm po-
sition, typically induced by elevation of the arms [16].
Fig. 7 Transient interruption of
contrast bolus results in
suboptimal opacification of the
pulmonary artery on initial
contrast bolus, with subsequent
diagnostic scan for pulmonary
embolus after repeat injection
using high pitch FLASH CTA.
The initial CECT (a) shows poor
opacification of the pulmonary
artery despite high density
contrast material within the aorta
and SVC because deep
inspiration resulted in increased
venous return from the IVC and
dilution of the contrast bolus in
the right heart (b) at the time of
scanning. Repeat injection using
high pitch FLASH technique with
free breathing (c) shows excellent
opacification of the pulmonary
artery
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Dynamic CTA, with the arm in neutral position and then in
elevated positions (130° of hyperabduction with external ro-
tation), can be used to evaluate TOS [17, 18]. Contrast injec-
tion should be administered into the vein of the asymptomatic
extremity to reduce beam hardening artifact [17, 18].
As the majority of thoracic CTAs are performed with the
patient’s arms raised, compression of the subclavian vein
(asymptomatic or symptomatic) can lead to compromises in
IV contrast delivery to the central vascular structures, affect-
ing bolus timing and leading to suboptimal opacification due
to reductions in flow rate (Fig. 5a). If suboptimal contrast
opacification of the target vessel is present, reimaging the
patient with the arm in the neutral or adducted position should
relieve the dynamic narrowing of the thoracic outlet, thereby
improving opacification of the vessel (Fig. 5b). Secondary
signs of venous stenosis include dynamic collateral vessel
filling and distal venous thrombus in chronic cases (Fig. 6).
Thoracic venous outlet obstruction should be considered
when extensive collateral vessel filling is seen on the side of
contrast administration when the patient’s arms are raised.
Alternatively, new access from the contralateral extremity
vein can be obtained.
Transient interruption of the contrast bolus
Considered a physiologic artifact, transient attenuation or
interruption of the contrast bolus refers to disruption of the
normal opacified contrast column secondary to return of
unopacified venous blood via the inferior vena cava
(IVC) in the setting of deep inspiration (Fig. 7a and b).
There are two significant imaging consequences of this
artifact: missing a true pulmonary embolus due to de-
creased opacification of the pulmonary artery or
misinterpreting the decreased vessel attenuation as an em-
bolus when it is not present. The pathophysiologic mech-
anism of this artifact is secondary to the normal variable
inflow of blood to the right heart during inspiration.
Referred to as the Babdominal-thoracic pump^, initial deep
Fig. 9 Cardiomyopathy resulting in poor contrast opacification of the left
atrium, left ventricle and aorta on a thoracic CTA being obtained to
evaluate for pulmonary embolism on a 64 slice CT. CECT demonstrates
excellent opacification of the right heart, but poor opacification in the left
heart related to prolonged pulmonary circulation time in a patient with left
ventricular systolic dysfunction. BNP was immediately obtained and was
elevated at 23,000, echocardiogram obtained within the next 4 h
demonstrated a left ventricle EF of 22 %
Fig. 10 Mixing artifact in the left atrium in a patient with severe mitral
regurgitation. CECT shows marked left atrium enlargement (arrow) with
mixing of opacified blood coming from pulmonary veins and non-
opacificed blood from the left ventricle due to severe mitral regurgitation
Fig. 8 Asystole with no cardiac output. Patient with cardiac arrest at the
time of CTA for acute aortic syndrome. Axial CTA at the level of the
carina (a) shows no opacification of pulmonary artery, ventricles, or aorta.
The CT technician subsequently called the radiologist to check the
images and ask for a repeat injection after identifying abnormal contrast
enhancement. Review of the axial images in the upper abdomen (b)
reveal contrast reflux into IVC, dependent hepatic veins, and a blood-
contrast level in the IVC. Contrast opacifies the right portal vein second-
ary to backflow from hepatic vein into portal vein. Contrast opacification
is of the dependent vasculature only. This prompted initiation of cardio-
pulmonary resuscitation and calling the code team. See also Movie 1
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inspiration decreases intrathoracic pressure and increases
intraabdominal pressure, acutely increasing venous return,
favoring flow from the IVC over the superior vena cava
(SVC), resulting in a bolus of nonopacified blood entering
the right heart from the abdomen [19, 20].
This artifact should be considered when there is decreased
opacification of multiple bilateral pulmonary arteries at the
same level without vessel lumen distention: true pulmonary
emboli typically present at various levels and normally expand
the vessel lumen acutely [19]. In patients unable to hold
breath, alternatively a free breathing high pitch flash CTA
may be obtained [21] (Fig. 7c).
Imaging pearl: Techniques to overcome this artifact often
rely on patient respiratory coaching, as the command Btake a
breath in and hold it^ can lead some patients to take a rapid
deep inspiratory breath, increasing the risk of transient atten-
uation of the contrast bolus. Alternate breathing instructions
include requesting the patient to stop breathing or to take a
slow gentle breath [20, 22].
Cardiac causes of poor non-target vessel opacification
Sequential contrast opacification of central veins and cardiac
chambers can be observed when bolus timing technique is
used to identify contrast arrival. Normal sequence of enhance-
ment follows right atrium, right ventricle, pulmonary artery,
pulmonary vein, left atrium, left ventricle, and aorta. Earlier
opacification of a distal chamber may be an indicator of intra
or extra-cardiac shunt. When using bolus tracker technique,
failure to adequately opacify the target vessels to reach the
threshold needed for triggering the scan may also be an
indication of decreased cardiac pump function.
Although the real incidence of cardiac arrest at the time of
CT is not known, it is probably not rare [23]. In these patients,
the contrast is distributed almost entirely in the venous system
with no opacification of the right ventricle, pulmonary artery
or aorta and indicates circulatory dysfunction (Fig. 8a and b).
There may be retrograde opacification of IVC, hepatic veins,
and even portal vein with dependent pooling of the contrast
forming a blood-contrast level (Movie 1) [24]. The distribu-
tion of contrast medium is now being determined by the push
from the power injector and the viscosity of the contrast me-
dium. These patients are likely hemodynamically unstable at
the time of presentation and may be on cardiopulmonary mon-
itoring which should be evaluated by the attending radiologist.
If the patient is not being monitored, and when such a finding
is seen on a nondiagnostic CTA, it is imperative to call the
code team and immediately begin cardiopulmonary resuscita-
tion rather than planning for a reinjection.
A less dramatic, but equally important observation may be
seen in patients with congestive heart failure with resultant
poor or no opacification of left cardiac chambers and aorta
during a CT pulmonary angiogram (Fig. 9). The likely expla-
nation for these findings can be increased pulmonary transit
time. When using a scanner with shorter acquisition time, non
target vessel enhancement may be less than expected, and these
Fig. 12 Two images from a CTPE study obtained in a patient with
tricuspid atresia and bidirectional cavopulmonary connection
demonstrate poor opacification of right pulmonary artery and non-
enhancement of left pulmonary artery (a). Findings could represent
thrombus. Delayed images (90 s) demonstrate complete opacification of
both pulmonary arteries and the intracardiac Fontan (b, also seeMovie 2).
In addition, notice the higher attenuation in the right superior and inferior
pulmonary veins compared to the adjacent pulmonary artery. This is
similar to contrast attenuation in SVC. Careful attention demonstrates
mediastinal venous collaterals draining directly into the pulmonary veins
forming an extra-cardiac right to left shunt
Fig. 11 Pericardial tamponade on CECT. Axial CTA shows moderate
pericardial effusion and heterogeneous enhancement of descending aorta
with blood contrast layering. This is indicative of poor stroke volume
from tamponade
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vessels should be interpreted with caution. Contrast-blood
mixing artifacts are often seen in the right atrium, right ventricle
and pulmonary artery during a pulmonary artery CTA due to
unopacified blood returning from the IVC. These are, however,
not commonly seen in left atrium or left ventricle, and whenever
seen should be considered abnormal (Fig. 10).
Decreased systolic function of left ventricle can result in
dependent contrast pooling and layering in the aorta [25]. This
is likely due to decreased stroke volumewith resultant contrast
blood pooling with dependent layering of the higher viscosity
contrast. Such dependent contrast pooling in descending aorta
can also be seen in patients with acute cardiac tamponade,
likely due to decreased stroke volume (Fig. 11).
Imaging Pearl: In patients with known heart failure, test bo-
lus can be more useful in identifying time to peak enhancement,
which can be delayed compared to contrast arrival time. Use of
delayed images after 30 s can help differentiate soft plaque/
thrombus from slow flow when dependent pooling is seen.
Differential enhancement of pulmonary arteries
Differential enhancement of pulmonary arteries during a pul-
monary artery CTA can be seen in patients with Fontan circu-
lation (Fig. 12), extra-cardiac shunts such as patent ductus
Fig. 14 Coronal reformat from a thoracic CTA in a 13-year-old patient
with mid aortic syndrome demonstrates step ladder artifact in the pulmo-
nary artery as well as descending aorta. Note the differential enhancement
in the right ventricle outflow tract vs. main pulmonary trunk. Also note
the differential enhancement in descending aorta
Fig. 13 Axial CT images from a
patient with coronary artery to
pulmonary artery fistula, which
results in partial opacification of
the main pulmonary artery while
contrast is maximally opacifying
the aorta, seen on axial CTA (a, b)
and conventional angiography
(c). On conventional
angiography, the fistula is seen
opacifying on the arterial phase
(arrow). The result is a systemic
to pulmonary artery shunt. Notice
the large thrombus in the A-V
malformation abutting the main
pulmonary artery
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arteriosus, bronchial artery, or coronary artery fistulas
(Fig. 13), and when using prospective ECG triggered CTA
(Fig. 14). Cavopulmonary shunts that connect the caval and
pulmonary circulation are performed in patients with single
ventricle physiology. Glenn shunt is performed as the second
stage of surgical repair and involves anastomosis between the
SVC and the right pulmonary artery, which can either be uni-
directional or bidirectional. Fontan shunt is performed as the
third stage of ventricular repair and involves anastomosis be-
tween the IVC and the left pulmonary artery. In the lateral
tunnel Fontan, the right atrial wall is used to create a baffle,
whereas in an extra-cardiac Fontan, a conduit is used to con-
nect IVC blood to the pulmonary artery. In classic Fontan, the
right atrium and the pulmonary artery are anastomosed. Total
cavopulmonary connection involves a Glenn shunt
connecting SVC to the right PA and Fontan shunt connecting
IVC to left PA. CT angiography in these patients to visualize
the pulmonary arteries or the conduits themselves is challeng-
ing since the SVC flow is directed to the right lung and the
IVC flow is directed to the lung (Fig. 13a). Hence, injecting
contrast only through the armwill not result in opacification of
the left pulmonary arteries and injection through the lower
extremity will not result in opacification of right pulmonary
arteries, resulting in non-diagnostic studies [26]. This is im-
portant since there is a higher risk of pulmonary thromboem-
bolism (3–19 %) in these patients [27]. Furthermore, due to
the absence of pumping action of right ventricle, there is pas-
sive laminar flow of Fontan circulation, which causes inho-
mogeneous enhancement, particularly within the conduit [28].
It has been shown that 13 % of these patients have mural
thrombus in the extracardiac conduit [27], even without symp-
toms, which may be missed with suboptimal studies [27]
Solutions for this are (1) Simultaneous upper and lower ex-
tremity (femoral vein/foot vein) injections at 4–5 mL/s, so that
both the SVC and IVC are opacified simultaneously [27].
However, the arrival of contrast media may not always be
simultaneous due to different resistance, collaterals, and flow
velocities. (2) Two-phase CT angiography, with both arterial
and delayed venous phases (Fig. 12b, Movie 2) [26]. Delayed
phase scan only. Delayed phase scan at 3 min has been shown
to be good in visualizing entire vasculature during recircula-
tion, regardless of the intravenous route or surgical technique
[28]. Some authors use a 1-min delay provided the injection is
antecubital due to shorter distance to pulmonary artery and in
Fig. 16 Mixing artifacts in the true lumen of the descending aortic
aneurysm with Type B aortic dissection which resolve on delayed phase
acquisition. Axial CECT (a) shows a type B dissection with mixing of
contrast in the true lumen (arrow). Delayed phase CECT in the same
patient (b) shows resolution of the mixing artifact. Note the complete
nonopacification of false lumen. This phase allows more accurate
estimation of the extent of the false lumen thrombus and slow flow
Fig. 15 Axial CT image in 46-year-old patient with 20-year H/O essen-
tial hypertension presenting with chest pain being evaluated for aortic
dissection demonstrates differential enhancement of the ascending and
descending aorta due to severe stenosis from coarctation. Sagittal
CECT MIP image demonstrates differential opacification of the aorta
proximal and distal to the aortic coarctation with post-stenotic dilatation.
Pressure gradient measured during catheter angiography was 20 mm Hg
across the stenosis
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pa t i en t s wi th cavopulmonary connec t ions than
atriopulmonary connections [28].
Differential enhancement of thoracic aorta
Differential enhancement of ascending and descending
aorta during a thoracic aortic CTA can be seen by using a
prospectively triggered acquisition, coarctation, large an-
eurysms, and dissections. When prospective ECG gating is
used (Fig. 14), there may be a delay between consecutive
axial acquisitions which is exaggerated in the presence of
irregular heart rate. This can lead to differential enhance-
ment in different segments of the aorta, which merely in-
dicates different contrast density at different time points.
There is no solution to this artifact once acquired, but this
can be avoided by using spiral instead of axial acquisitions.
Differential aortic enhancement can also be seen in patients
with coarctation of aorta (Fig. 15). This is due to dilution of
contrast within the blood pool of the post stenotic dilated
aortic lumen. Unless sagittal images are also reviewed, this
subtle sign may be the only significant clue seen on axial
CTA images.
Fig. 18 Axial CTA images from
the same patient as in Fig. 17
obtained after the ECMO circuit
was put on minimal flow status
for a short period (25 s) to allow
for near physiologic circulation.
Axial (a) and coronal reformatted
pulmonary CTA (b) subsequently
demonstrates a large central
pulmonary embolism
Fig. 17 Sequential axial CT images (a–f) from a test bolus obtained at
the level of main pulmonary artery. Notice the altered pattern of contrast
flow. In a normal patient, contrast injected from the upper extremity first
opacifies the SVC, followed by the right atrium, right ventricle,
pulmonary artery, pulmonary vein, left atrium, left ventricle, ascending
aorta, and finally the descending thoracic aorta. In this case we see an
altered pattern of contrast flow: first SVC, followed by minimal
opacification of the pulmonary artery and ascending aorta, dense
opacification of the descending aorta followed by dense opacification of
the ascending aorta. There is insufficient opacification of the pulmonary
circulation due to siphoning of contrast by ECMO
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Mixing artifacts can be seen in large aortic aneurysms and
should not be confused with a thrombus (Fig. 16a). Delayed
images can help in opacification of the lumen (Fig. 16b).
Differential enhancement of false lumen of an aortic dis-
section can also be due to delayed opacification due to higher
inherent luminal pressures. This should not be confused with a
thrombus. In type B dissection, identification of false lumen
thrombus can be overestimated by first pass CTA/MRA. True
estimation of this false lumen thrombosis after aortic dissec-
tion is important as this can be important for prognosis [29].
Delayed phase acquisition is recommended for a more accu-
rate estimation of true extent of false lumen thrombus vs. slow
flow. Aortic dissection with partial thrombosis of the false
lumen has a significantly higher annual aortic growth rate
when compared with those patients with complete thrombosis
of the false lumen [30].
Imaging pearl: In patients with known aortic aneurysm,
ROI for test bolus or bolus tracking should be placed in that
portion of the aorta which has the largest diameter.
ECMO
Extracorporeal membrane oxygenation or ECMO is increas-
ingly being used in adults for pulmonary or cardiopulmonary
support in not just pediatric, but also adult patients with severe
respiratory failure or following failure to wean from cardio-
pulmonary bypass after cardiac surgery [31]. The hemody-
namics of flow in these patients, especially those on a
venoarterial ECMO, are altered, with retrograde flow occur-
ring in the access artery and in case of femoral artery access, in
the aorta [32]. This can lead to variable enhancement pattern
(Fig. 17a–f) of aorta, poor opacification of cardiac chambers,
and suboptimal enhancement of the pulmonary vessels.
Imaging Pearl: Different approaches have been suggested to
perform contrast-enhanced CTA in patients on ECMO: injec-
tion into the arterial cannula of the ECMO after the membrane
oxygenator or into the venous line distal to the membrane ox-
ygenator [33]. In our experience, slowing the flow of the circuit
to the minimal flow rate that would prevent thrombus forma-
tion for the duration of the scan (15–20 s) has worked well in
cases of suspected pulmonary embolism (Fig. 18).
Central venous catheters
Central venous catheters are often used for contrast injection.
Although there are safety issues related to this such as the risk
of catheter rupture, fragmentation, or thromboembolism, these
devices can be safely used if appropriate precautions including
manufacturer specifications are followed [34]. Studies have
shownthatvascularenhancement is superiorwithcentralvenous
catheter injectionscompared toperipheral route injectionsdue to
the short time to peak enhancement facilitated by shorter travel
distance for contrast bolus. There is also reduced individual
patientvariability [8].However, thecontrast injection is typically
performed slower than peripheral routes due to safety concerns.
Since the contrast media will directly opacify the lower SVC or
the right atriumand the subsequent cardiovascular structures, the
upperSVCandotherveinswillnotbeadequatelyopacifiedin the
first pass as with a peripheral route injection. Hence, if venous
visualization is the primary clinical objective, a delayed phase
should be obtained in addition to the arterial phase.
Imaging Pearl: Manufacturer recommendations for the cen-
tral venous catheter that is being used should be adhered to for
peak flow rate. A delayed phase, 40 s acquisition can help in
identifying any thrombus, vegetation, or fibrin sheath attached
to the catheter.
Conclusion
Non-diagnostic thoracic CTAs are frequently encountered in
clinical practice. Careful interpretation of power injector
graphs, location of region of interest to trigger the scan, and
pattern of contrast flow can help determine the cause. This can
help in planning a reinjection and obtain a diagnostic scan.
Pattern of opacification of non target vessels can be useful in
understanding the hemodynamic status of the patient and cor-
rectly identifying life threatening conditions such as
tamponade, heart failure, and asystole.
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